BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Mammalian target of rapamycin inhibitors
1
Efficacy and safety of low-dose everolimus and tacrolimus in kidney transplant recipients: A retrospective study
5/29/2026 8:41:36 AM | Browse: 37 | Download: 142
2
Mammalian target of rapamycin; novel insight for management of inflammatory bowel diseases
1/25/2022 7:27:40 AM | Browse: 851 | Download: 2135
3
Systemic meta-analysis assessing the short term applicability of early conversion to mammalian target of rapamycin inhibitors in kidney transplant
4/20/2017 8:08:00 PM | Browse: 1340 | Download: 2663
4
Organ transplantation and drug eluting stents: Perioperative challenges
12/14/2016 2:15:00 PM | Browse: 1141 | Download: 1659
5
Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation
3/18/2016 2:28:00 PM | Browse: 1093 | Download: 2040
6
Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients
12/23/2015 8:26:00 AM | Browse: 1478 | Download: 2649
7
Hepatocellular carcinoma: A comprehensive review
11/18/2015 11:12:00 AM | Browse: 1785 | Download: 2459
8
Conversion from calcineurin inhibitors to mTOR inhibitors stabilizes diabetic and hypertensive nephropathy after liver transplant
3/24/2015 5:37:00 PM | Browse: 1313 | Download: 2026
9
Hepatitis B reactivation related to everolimus
9/10/2014 3:18:00 PM | Browse: 1283 | Download: 921
10
“Targeting” renal cell carcinoma patients with “targeted” agents: Are we there yet?
9/3/2014 10:06:00 AM | Browse: 1089 | Download: 1357
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.